News Focus
News Focus
Followers 8
Posts 913
Boards Moderated 0
Alias Born 10/01/2020

Re: Hoskuld post# 500731

Tuesday, 09/16/2025 12:08:55 PM

Tuesday, September 16, 2025 12:08:55 PM

Post# of 517441
Agreed.

Investor14 and Doc keep on beating the drum about a confirmatory trial of some sorts!

I call bullshit, why on earth would EMA do that for?? There is absolutely no need to do that considering they approved the "Maps"

Now France is talking about stop funding lecanemab because it's not effective and expensive for the country.
Funnily enough, France has a lady professor (Dr. Audrey Gabelle), that speaks very warmly about 2-73, hmmmmmm!!

UK (not in the EU) has approved lecanemab but don't pay for it.
NHS rejection: The National Institute for Health and Care Excellence (NICE), which assesses whether drugs can be offered on the NHS, did not recommend lecanemab for public funding.
NICE determined that the drug's benefits, which it considered to be relatively small, did not justify the high costs of the medicine, infusions, and monitoring.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News